Human leukocyte antigen variants associate with BNT162b2 mRNA vaccine response
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Human leukocyte antigen variants associate with BNT162b2 mRNA vaccine response ; volume:4 ; number:1 ; day:4 ; month:4 ; year:2024 ; pages:1-7 ; date:12.2024
Communications medicine ; 4, Heft 1 (4.4.2024), 1-7, 12.2024
- Urheber
-
Esposito, Martina
Minnai, Francesca
Copetti, Massimiliano
Miscio, Giuseppe
Perna, Rita
Piepoli, Ada
De Vincentis, Gabriella
Benvenuto, Mario
D’Addetta, Paola
Croci, Susanna
Baldassarri, Margherita
Bruttini, Mirella
Fallerini, Chiara
Brugnoni, Raffaella
Cavalcante, Paola
Baggi, Fulvio
Corsini, Elena Maria Grazia
Ciusani, Emilio
Andreetta, Francesca
Dragani, Tommaso A.
Fratelli, Maddalena
Carella, Massimo
Mantegazza, Renato E.
Renieri, Alessandra
Colombo, Francesca
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s43856-024-00490-2
- URN
-
urn:nbn:de:101:1-2406182131038.089926788966
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Esposito, Martina
- Minnai, Francesca
- Copetti, Massimiliano
- Miscio, Giuseppe
- Perna, Rita
- Piepoli, Ada
- De Vincentis, Gabriella
- Benvenuto, Mario
- D’Addetta, Paola
- Croci, Susanna
- Baldassarri, Margherita
- Bruttini, Mirella
- Fallerini, Chiara
- Brugnoni, Raffaella
- Cavalcante, Paola
- Baggi, Fulvio
- Corsini, Elena Maria Grazia
- Ciusani, Emilio
- Andreetta, Francesca
- Dragani, Tommaso A.
- Fratelli, Maddalena
- Carella, Massimo
- Mantegazza, Renato E.
- Renieri, Alessandra
- Colombo, Francesca
- SpringerLink (Online service)
Ähnliche Objekte (12)
Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection
Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine?
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis
Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up
Humoral response after BNT162b2 vaccine in Japanese hemodialysis patients
Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination
Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection
Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine?
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis
Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up
Humoral response after BNT162b2 vaccine in Japanese hemodialysis patients
Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination
Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection
Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine?
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis
Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up
Humoral response after BNT162b2 vaccine in Japanese hemodialysis patients